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Available online 2 December 2015AbstractPurpose: To identify inflammatory and fibrotic mural stricture in Crohn's disease (CD) using MR diffusion-weighted imaging (DWI) and to
compare DWI findings with those of enteroscope and histological markers.
Method and materials: Thirty-one patients with CD (18 males, 13 females; mean age, 38.9 years) were recruited in this approved retrospective
study and an informed consent was obtained from each subject. All subjects underwent bowel MRI examination with conventional and DWI
sequences at 3.0 T. Colonoscopy results were distributed within 24 h after examination. According to the endoscopic manifestations and
pathological results, the patients were divided into two groups: inflammatory (21/31) and fibrotic (10/31).
Results: In the group of inflammatory stricture, the mean ADC value of stricture bowel was 1.4 ± 0.23  103 mm2/s, whereas
0.8 ± 0.16  103 mm2/s in the group of fibrotic stricture. Inter-group independent sample t-test was performed. A statistically significant
difference was observed (t ¼ 7.403, P < 0.05). The area under receiver-operating characteristic curve was 0.981 (95% confidence interval,
0.943e1.000), with 1.11  103 mm2/s as the cutoff point. The sensitivity of low ADC values in detecting inflammatory bowels was 90.5%, and
the specificity of high ADC values in excluding inflammatory bowels was 100%.
Conclusion: Decreased ADC values in inflammatory stricture bowel may be resulted from multiple factors, including an increase in cellularity,
presence of edema, micro-abscesses and increased perfusion. Meanwhile, fibrotic tissue deposition was indicated to lead to restrictions in
diffusion. Distinguishable ADCs were observed between inflammatory and fibrotic bowel stricture, where DWI sequence could contribute to the
identification.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Beijing You’an Hospital affiliated to Capital Medical University. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Crohn's disease (CD) is a chronic, relapsing inflammatory
disorder of unknown causes with an onset usually in early
adulthood. CD is characterized by multiple discontinuous
areas of bowel inflammation, distributed throughout the* Corresponding author.
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open access article under the CC BY-NC-ND license (http://creativecommons.org/gastrointestinal tract, often complicated by strictures, ab-
scesses, and fistula formations. Stricture is a common
complication of CD, occurring in 1/3 of patients after 10 years
of disease [1]. Over time, chronic inflammation within the
bowel wall progresses to mural fibrosis. When fibrosis is
associated with stricture formation, bowel obstruction may
develop. It is important to identify fibrotic strictures with
certainty because they are unresponsive to medical therapy.
Endoscopic examination is a mainstay for evaluation, but is
limited in the presence of severe strictures. Medical imaging
plays a key role, measuring disease activity, and identifyingof Beijing You’an Hospital affiliated to Capital Medical University. This is an
licenses/by-nc-nd/4.0/).
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radiation exposure, particularly if they are young or have had
multiple scans in a short period of time. Currently, Magnetic
resonance imaging (MRI) is regarded to be the optimal
imaging modality for assessment of complications of Crohn's
disease.
MR diffusion-weighted imaging (DWI) sequence uses the
differences in the motion (diffusion) of water molecules in
extracellular and intracellular fluid and vascular fluids to pro-
duce image contrast, with no need for exogenous contrast ma-
terials. This imaging technique provides both qualitative and
quantitative information at the cellular level with regards to
tissue cellularity and cell membrane integrity and is hence
considered a form of functional imaging [2]. Diffusion is
inversely related to cellularity, cell membrane integrity and
lipophilicity. Restricted (or impeded) diffusion is observed in
tissues with high cellularity, e.g., tumors, abscesses, fibrosis and
cytotoxic edema [3]. The calculated apparent diffusion coeffi-
cient (ADC) is a quantitativemeasure of tissue diffusivity and is
expressed in ( 103) as mm2/s. ADCs have been shown to be
useful for differentiating severe hepatic fibrosis from mild or
moderate fibrosis [4]. Theoretically, DWI should be able to
differentiate inflammatory strictures from fibrostenotic lesions
in CD due to different water content of the two tissue types. This
area is of enormous clinical importance, because the presence of
a fibrotic stricturewithout significant inflammationwould direct
a patient to surgical therapy rather than continued medical
therapy [5]. However, to our knowledge, no study has correlated
ADC value of MR DWI sequence e derived estimates of
stricture in Crohn's disease with results of matched detailed
enteroscope and histological analysis.
The purpose of this study was to identifying the inflam-
matory and fibrotic mural stricture in CD by using DWI and
then to correlate it with enteroscope and histological markers.
2. Materials and methods2.1. Patient EnrollmentThis retrospective study was conducted with approval from
the medical ethics committee of the Second Affiliated Hospital
of Nanjing Medical University (approved: 2013-KY-034). All
enrolled subjects were patients with histologically proven CD.
Written informed consent was obtained for performance of the
MRI rule and DWI sequence examination, which was the
research study. For subjects younger than 18 years, written
informed consent was obtained from a parent. Study exclusion
criteria included the inability to undergo MRI without
conscious sedation, the presence of MRI-incompatible
metallic hardware.2.2. Research playAll MRI examinations performed were evaluated by two
experienced radiologists independently with the aim of
differentiating active inflammatory from fibrotic stricture.
Histological findings were used as a reference.Patients with CD underwent conventional MRI scan and in-
testinal stricture was located (A stricture was judged present if a
bowel segment had >80% lumen reduction as compared to an
adjacent normal loop and mural thickening of >3 mm [6]). The
stricture bowel was divided into six segments: terminal ileum,
cecum, ascending colon, transverse colon, descending colon,
and rectosigmoid colon. The perianal region and small-bowel
loops other than terminal ileum were not specifically assessed
in this study. DWI sequence performed in the stricture bowel
segment. DWI of the bowel (b values, 0 and 600 s/mm2) was
independently evaluated by two radiologists (with a combined
10 years of body MRI experience), who were blinded to the
clinical and endoscopic examination, on a workstation with
commercially available diffusion analysis software (Advantage
Windows version 4.6; GE Healthcare). For the ADC measure-
ments, the images were magnified, and the oval regions of in-
terest (ROI) were placed on the largest possible area covering
the bowel wall. ROI areas varied from 12 to 30 mm2. The mean
of the two ADC values (measured by different radiologists) was
accepted as the ADC value of the segment.
All patients underwent colonoscopy in the next 24 h and
had biopsy taken according DWI scanning position (Referring
to the bony landmarks such as lumbar, ilium). Histology was
adopted as the gold standard. Based on histopathology a
stricture was classified as inflammatory or as fibrotic. The
ambiguous cases, in which the coexistence of fibrosis and
inflammation did not allow an accurate judgment of the actual
cause of the stricture, were excluded from the study.
A total of 31 patients (mean age, 38.9 years; range, 21e71
years), including 18 men (mean age, 38.6 years; range, 22e71
years) and 13 women (mean age, 39.3 years; range, 21e63
years), were enrolled in the study.2.3. MRI techniqueAll MRI examinations were performed in the supine posi-
tion with a 3.0 T clinical scanner (Signa HDxt, GE Healthcare)
equipped with coil (GE Healthcare) in the abdominal-pelvic
configuration (8 radiofrequency channels). No special patient
preparation other than a 6-h fast without intake of solid foods
was requested prior to MRI. Our protocol required the patient
to drink 300 mL of mannitol (2.5%) every 10 min until a total
of 1.5 L has been consumed over the course of 60 min just
before MRI scanning. Immediately before imaging, all pa-
tients were given intravenous administration of 20 mg of
scopolamine-N-butyl bromide (Busco-pan; Boehringer Ingel-
heim, Ingelheim, Germany) to reduce motion artifacts arising
from bowel peristalsis.
MRI rule sequences included three-plane localizers, coro-
nal and axial images through the entire abdomen and pelvis:
FIESTA (8 mm/10 gap; TR,3.3 ms; TE, 100 ms; matrix,
256  128); coronal T2 ssfse through the abdomen and pelvis
(single shot fast spin-echo; 5 mm/1 gap; TR/TE, 2800/70;
breath-hold); axial T2 fast spin-echo fat-suppressed images
through the abdomen and pelvis (4 mm/2 gap; TR/TE, 12000/
90; free-breathing with navigator triggering); axial T1 LAVA-
Flex Mask through the abdomen and pelvis (4 mm/0 gap; TR/
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abdomen and pelvis with three artery phases after injection;
and coronal T1 LAVA-Flex through the abdomen and pelvis
(4 mm/0 gap; TR/TE, 5.1/1.8; field of view, 40 cm; breath-
holds). IV administered contrast agent was gadopentetate
dimeglumine (Magnevist, Bayer) at a dose of 0.1 mmol/kg
injected at 2 mL/s using a power injector followed by a 20-mL
saline flush at the same rate.
MR DWI sequence: axial images; 4 mm/0 gap; TR/TE,
6600/min; matrix, 128  128e224; field of view, 40 cm; b
value, 600 s/mm2; diffusion of direction, 3 in 1; number of
signals acquired, 6.
Total MRI scan times ranged from 45 to 60 min.2.4. Statistical analysisNormally distributed data are presented as means ± standard
deviation. Paired t tests were used to examinewhether there was
a difference between the measurements of two radiologists. All
data were test with the one-sample KolmogoroveSmirnov test
for normally distributed; groups were compared with the Lev-
ence's test for equality of variances. A receiver-operating char-
acteristic curve was constructed for ADC values, and the area
under the curve was a measure of the overall ability of
discriminating inflammatory and fibrotic stricture bowels. All
statistical tests were performed two-sided at the level of
P< 0.05. Analysis was performed with the IBM SPSS Statistics
19 software package for Windows.Fig. 1. A 29-year-old man with known Crohn's disease. Conventional MRI (aec) sh
(arrow). The stricture bowel is markedly enhanced (dee) and accompanied by m
(b ¼ 600 s/mm2) through the abdomen (f) shows increased signal and thickening of
and hyperplastic polyps in the descending colon (hei).3. Results
According to the rule MRI manifestations, a single segment
of the stricture bowel was chosen to undergo DWI scanning in
each patient. A total of 31 DWI sequence data were collected
in this study. According to the follow-up colonoscopy, the 31
stricture bowels were divided into group of inflammatory
stricture (n ¼ 21) and group of fibrotic stricture (n ¼ 10). MRI
manifestations were shown in Fig. 1 and Fig. 2; grouping was
summarized in Table 1.
The interobserver agreement in ADC measurements
are shown in Fig. 3. The BlandeAltman concordance
correlation coefficient was 0.971 (P ¼ 0.000 < 0.05) for the
two measurements by two radiologists, and the mean
difference was 0.00 ± 0.09  103 mm2/s (P > 0.05).
These data suggested that interobserver reliability was very
good.
The mean ADC value of proven inflammatory bowels was
1.4 ± 0.23  103 mm2/s (range, 1.01e1.83  103 mm2/s),
compared to 0.8 ± 0. 16  103 mm2/s (range,
0.534e1.03  103 mm2/s) in fibrotic bowel segments
(t ¼ 7.403, P ¼ 0.000 < 0.05) (Table 2). The area under the
receiver-operating characteristic curve was 0.981 (95% con-
fidence interval, 0.943e1.000). Using 1.11  103 mm2/s as
the cutoff point, the sensitivity of low ADC values for
detecting inflammatory bowels was 90.5%, and the specificity
of high ADC values for ruling out inflammatory bowels was
100% (Fig. 4).ows localized bowel wall thickening, luminal stricture in the descending colon
esenteric vascular proliferation (arrowheads). Axial diffusion-weighted image
the descending colon wall. Colonoscopy showed active colitis with ulceration
Fig. 2. A 31-year-old woman with known Crohn's disease. Conventional MRI examination showes sigmoid bowel wall thickening and mild enhancement after
enhanced (aec). Axial diffusion-weighted image (b ¼ 600 s/mm2) through the pelvis (d) demonstrates restricted diffusion in the stricture wall (arrowheads).
Colonoscopic biopsy showed fibrous tissue hyperplasia, without ulcer and polyp (eef).
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In CD patients with strictures, it is important to distinguish
between inflammatory stricture and fibrotic stricture, as
obstruction in active CD may be relieved by medical treatment
whereas fibrotic strictures may require surgical intervention.
Rule MRI can provide some information in this setting by
differentiating between inflammatory and fibrotic stricture
according to the signal intensity of T2WI, the degree and
pattern of mural enhancement and changes the mesenteric
structure around the lesion segment [6e10]. However, these
criteria are lack of quantitative data.
Our results indicate that DWI sequence yields quantitative
information (ADC values) and that could contribute to iden-
tification of the inflammatory and fibrotic bowel stricture in
CD. To our knowledge, this finding has not been previously
published.Table 1
The position and number of stricture bowel in group of inflammatory/fibrotic.








Terminal ileum 6 2
Cecum 3 1
Ascending colon 2 1
Transverse colon 4 1
Descending colon 2 3
Rectosigmoid colon 4 2
Total 21 10DWI can provide reliable quantitative measures of lesion
bowel, so this imaging tool has been investigated in the
assessment of bowel inflammation in CD. There are some
studies on the role of DWI in detection of bowel inflammation
in CD. ADC may facilitate quantitative analysis of disease
activity. Oto et al. [11] reviewed DWI images of 11 CD pa-
tients and measured ADC values in a pilot study. They
concluded that inflammatory bowel segments showed higher
signal and decreased ADC values compared to normal seg-
ments. Kiryu et al. [12] found lower ADC values in the
disease-active than that in disease-inactive area in CD patients.
Neubauer et al. [13] indicated a significant correlation between
wall thickness and ADC in inflammatory segments. In
conclusion, visual assessment of DWI may provide higher
accuracy, and the calculation of the ADC may facilitate the
quantitative analysis of disease activity.
It is unclear why intestinal inflammatory lesions have
restricted diffusion that is translated into a hyperintense signal
on DWI and decreased ADC values relative to normal seg-
ments. A potential pathogenetic mechanism may be a reduc-
tion in extracellular space secondary to cell swelling or
increased cell density. A number of factors may lead to this
reduction, including an increase in cellularity, migration of
lymphocytes into the inflammatory wall segments, presence of
edema, micro-abscesses and increased perfusion. In
inflammatory segments, the lamina propria and submucosa are
infiltrated by inflammatory cells. Aphtoid ulcers, characteristic
lesions of CD, are also strongly associated with lymphoid
aggregates. These lymphoid aggregates have restricted diffu-
sion within themselves because of the increased cell density,
as well as further limiting the diffusion by narrowing the
Fig. 3. Bland-Altman Plot. BlandeAltman 95% limits of agreement in apparent diffusion coefficient (ADC): interobserver agreement (concordance correlation
coefficient was 0.971, P ¼ 0.000 < 0 0.05).
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number of inflammatory cells, dilated lymphatic channels,
hypertrophied neuronal tissue, and the development of gran-
ulomas in the bowel wall can further narrow the extracellular
space and therefore contribute to the restricted diffusion of
water molecules. Accompanying intracellular changes within
both the epithelial and inflammatory cells may also have an
effect on the changes in diffusion.
In the later stages of CD, mural fibrotic stricture frequently
leads to irreversible narrowing intestines associated with
proximal bowel obstruction [14]. In CD, fibrosis can involve
the entire bowel wall including the mucosa, submucosa,
muscularis, mucosa, muscularis propria and serosa layers.
Intestinal fibrosis results from an abnormal response to a
chronic local injury and is characterized by abnormal pro-
duction and deposition of excessive extracellular matrix
(ECM) proteins by activated myofibroblasts, also called ECM-
producing cells [15]. Therefore, collagen fiber deposition in
the bowel wall and myofibroblasts have been suggested to play
a key role in intestinal fibrosis [9,16,17].There is also limited
information concerning the possible influence of fibrosis on
the global DWI signal or ADC values. Several studies have
shown that ADCs are lower for cirrhotic liver than normal
liver [18] and DWI can be used for assessing the presence of
moderate and advanced liver fibrosis [19], possibly because
the greater presence of connective tissues in the liver,Table 2
Statistical comparison between the two groups. Statistics show that all the data of AD





test for normally distributed
Group of inflammatory stricture 21 KolmogoroveSmirnov Z ¼
P ¼ 0.857Group of fibrotic stricture 10narrowed sinusoids, and decreased blood flow with cirrhosis
[20]. A similar effect of fibrosis may also be possible in the
bowel wall. So, fibrotic tissue deposition is known to cause
restriction in diffusion.
Wang et al. showed liver parenchyma with chronic hepatitis
and without fibrosis had a significantly higher median ADC
value than those of parenchyma with each stage of fibrosis
[21]. According to Li H et al. [22], there was a decrease in
liver ADC with increasing degree of fibrosis, and moderate
negative correlations could be found between ADC values and
fibrosis stages. In this study it was demonstrated that the mean
ADC value of inflammatory bowels was higher than fibrotic
bowel segments. We hypothesize that the restriction of fiber
deposition on water molecules is greater than the cellular in-
flammatory edema.
Our study had several limitations due to its retrospective
design and small patient population. Firstly, our study popu-
lation was a small selected group of patients with a high pre-
test probability of CD. The analysis was confined to the colon
and terminal ileum, where endoscopic correlation was avail-
able. The rest of the small bowel was not included in the study.
Secondly, although we made our best effort by magnifying
images and using oval ROI to try to exclusively cover the
bowel wall, we can not completely exclude the possibility of a
partial volume effect on ADC measurements. In addition, we













0.605, 1.01e1.83 1.4 ± 0. 23 F ¼ 1.321,
P ¼ 0.260
t ¼ 7.403
P ¼ 0.0000.534e1.03 0.8 ± 0. 16
Fig. 4. Receiver-operating characteristic (ROC) curve for ADC.
133J. Zhu et al. / Radiology of Infectious Diseases 2 (2015) 128e133investigating DWI findings using different b values may
determine their role.
In conclusion, MR DWI sequence enables identification of
a stricture segment, definition of characteristics e whether
inflammatory or fibrous e and therefore guidance towards the
most appropriate treatment. This study shows sufficient
promise to merit larger clinical investigations. More cumula-
tive data through prospective large series is necessary to
establish their diagnostic role in clinical practice.
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